Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Hofseth Biocare ASA (HBC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.06 -0.03    -1.44%
10:25:06 - Closed. Currency in NOK ( Disclaimer )
Type:  Equity
Market:  Norway
ISIN:  NO0010598683 
S/N:  NO0010598683
  • Volume: 34,575
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 2.02 - 2.08
Hofseth Biocare 2.06 -0.03 -1.44%

Hofseth Biocare ASA Company Profile

 
Get an in-depth profile of Hofseth Biocare ASA, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryFood & Tobacco
SectorConsumer Non-Cyclicals
Employees

60

Equity Type

ORD

Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company’s products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was incorporated in 2000 and is headquartered in Ålesund, Norway.

Contact Information

Address Keiser Wilhelms gate 24
Ålesund, 6003
Norway
Phone 47 73 10 22 00
Fax -

Top Executives

Name Age Since Title
Torill Standal Eliassen 49 2015 Independent Director
Roger Hofseth 50 2017 Chair of the Board
Christoph Johannes Baldegger 53 2015 Independent Director
Amy Novogratz - 2021 Independent Director
Crawford Currie - 2022 Head of Medical R&D and Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

HBC Comments

Write your thoughts about Hofseth Biocare ASA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
luca simioni
luca simioni Nov 12, 2020 12:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
importants news will be announced by the end of the year, in particular the compagnie will confirm the deal (distribution agreement- confirmantion of the letter of intent agreed with Garden of life (Nestlé) for the distribution of their main products across NorthAmerica. to be announced by the end of the year together with their new cotation at the Oslo Bors (Key place for institutional investors.) increase in sales and overexpected achievements in R&D will serve as a catalyst to drive the price above NOK 10 by the end of the year and further much higher by mid year 2021. written in stone.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email